BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Golden State Equity Partners's Holding History (CIK: 0001845003)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023

Shares 11,430 Value ($000) $68 Avg Close $5.79 Range $4.83 - $7.06

Q3 2023

Shares 10,925 Value ($000) $77 Avg Close $7.18 Range $6.62 - $7.95

Q2 2023

Shares 10,925 Value ($000) $77 Avg Close $8.02 Range $6.87 - $9.07

Q1 2023

Shares 10,925 Value ($000) $91 Avg Close $9.63 Range $7.82 - $12.08

Q1 2022

Shares 11,435 Value ($000) $186 Avg Close $16.04 Range $11.56 - $19.99

Q4 2021

Shares 11,435 Value ($000) $158 Avg Close $13.23 Range $10.72 - $15.77

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2023	11,430	$68	$5.79	$4.83 - $7.06
Q3 2023	10,925	$77	$7.18	$6.62 - $7.95
Q2 2023	10,925	$77	$8.02	$6.87 - $9.07
Q1 2023	10,925	$91	$9.63	$7.82 - $12.08
Q1 2022	11,435	$186	$16.04	$11.56 - $19.99
Q4 2021	11,435	$158	$13.23	$10.72 - $15.77